Kimi K2.6 builds on Kimi K2.5 with stronger coding, better tool use, lower hallucination rates, native multimodal input, and ...

AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia (CLL), in combination with an AstraZeneca drug. The ...

If you’ve ever tried to follow a trend using technical charts, you know the frustration: indicators can often feel too slow. By the time a traditional signal confirms a move, the best part of the ...

Our Goal In the fast-evolving landscape of AI, we saw an opportunity to revolutionize local election coverage in our newsroom by reducing manual, repetitive tasks so our journalists could focus on ...